Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis- Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and S ...

Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2908
https://www.valueinhealthjournal.com/article/S1098-3015(15)04989-X/fulltext
Section Title : Research Podium Presentations - Session 1 and Session 2
Section Order : 2310
First Page : A751
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04989-X&doi=10.1016/j.jval.2015.09.2908
HEOR Topics :
Tags :
Regions :